SANOFI CONS HEALTHC IND L (NSE:SANOFICONR) — Market Cap & Net Worth
Market Cap & Net Worth: SANOFI CONS HEALTHC IND L (SANOFICONR)
SANOFI CONS HEALTHC IND L (NSE:SANOFICONR) has a market capitalization of $1.19 Billion (Rs109.72 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #8374 globally and #396 in its home market, demonstrating a 4.01% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SANOFI CONS HEALTHC IND L's stock price Rs4763.90 by its total outstanding shares 23030622 (23.03 Million). Analyse SANOFICONR cash flow metrics to see how efficiently the company converts income to cash.
SANOFI CONS HEALTHC IND L Market Cap History: 2024 to 2026
SANOFI CONS HEALTHC IND L's market capitalization history from 2024 to 2026. Data shows change from $1.23 Billion to $1.19 Billion (-1.76% CAGR).
SANOFI CONS HEALTHC IND L Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SANOFI CONS HEALTHC IND L's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.13x
SANOFI CONS HEALTHC IND L's market cap is 0.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.47x
SANOFI CONS HEALTHC IND L's market cap is 0.47 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.23 Billion | $7.25 Billion | $1.81 Billion | 0.17x | 0.68x |
| 2025 | $1.13 Billion | $8.78 Billion | $2.40 Billion | 0.13x | 0.47x |
Competitor Companies of SANOFICONR by Market Capitalization
Companies near SANOFI CONS HEALTHC IND L in the global market cap rankings as of May 4, 2026.
Key companies related to SANOFI CONS HEALTHC IND L by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $862.20 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $547.37 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $365.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16 | Eli Lilly and Company | NYSE:LLY | $862.20 Billion | $963.33 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #23 | Johnson & Johnson | NYSE:JNJ | $547.37 Billion | $227.19 |
| #37 | AbbVie Inc | NYSE:ABBV | $365.30 Billion | $206.60 |
SANOFI CONS HEALTHC IND L Historical Marketcap From 2024 to 2026
Between 2024 and today, SANOFI CONS HEALTHC IND L's market cap moved from $1.23 Billion to $ 1.19 Billion, with a yearly change of -1.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.19 Billion | +5.40% |
| 2025 | Rs1.13 Billion | -8.27% |
| 2024 | Rs1.23 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of SANOFI CONS HEALTHC IND L was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.19 Billion USD |
| MoneyControl | $1.19 Billion USD |
| MarketWatch | $1.19 Billion USD |
| marketcap.company | $1.19 Billion USD |
| Reuters | $1.19 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more